NEWS
Questionnaire for Meta Hunter Bioresonance machine Therapy
A questionnaire with 75 questions was used to record the data and was distributed to all patients. The questionnaire consisted of 75 questions to be answered by all patients who used the bioresonance method and completed or stopped treatment with the Meta
Questionnaire for Metatron Hunter Bioresonance machine Therapy
A questionnaire with 75 questions was used to record the data and was distributed to all patients. The questionnaire consisted of 75 questions to be answered by all patients who used the bioresonance method and completed or stopped treatment with the Meta
Raising health awareness is important
Many people think that going to the hospital to check your physical condition is troublesome. This kind of thing will become a thing of the past. Now we have Metapathia GR Hunter. You only need to live quietly at home, and the device will quickly check your physical condition, analyze your physical data, and tell you Physical risks, how convenient is this? You can even help your family, neighbors, and friends with testing.
Relieve anxiety with the Biophilia Tracker X4 MAX device
The Biophilia Tracker X4 MAX device can not only help regulate our anxiety, but also allow us to detect health problems in our body earlier, so that we can treat and respond to them earlier.
Remote black box's principle
Remote black box use this principle,can do remote test and treatment.
Retrospective Surgery Study of the Therapeutic Effectiveness of the META-HUNTER Bioresonance Therapy in Conventional Therapy-Resistant Patients Suffering from Allergies, Pain and Infection Diseases
Abstract
Background: Allergic diseases, chronic pain, and infectious diseases often show resistance to conventional therapies, imposing heavy burdens on patients. META-HUNTER bioresonance therapy, a non-invasive complementary approach, may provide a new solution. This retrospective study aimed to evaluate its effectiveness in refractory cases. Methods: A retrospective analysis was conducted on 186 patients (2018–2022) with allergies, pain, or infections who failed ≥3 months of conventional therapy. META-HUNTER therapy was administered for 4–8 weeks. Therapeutic effectiveness was assessed by disease-specific criteria, and safety was monitored. Results: The overall effective rate was 79.6%: 82.1% for allergies, 77.4% for pain (VAS score decreased from 7.2±1.5 to 3.1±1.2, P<0.05), and 76.1% for infections. Only 6.5% of patients had mild transient adverse reactions. Conclusion: META-HUNTER bioresonance therapy is effective and safe for conventional therapy-resistant patients, providing a new therapeutic option. Further prospective trials are needed to verify long-term effects.
1. Introduction
Allergic diseases, chronic pain, and infections are prevalent, but many patients are unresponsive to conventional treatments (drugs, immunotherapy, symptomatic management), leading to poor quality of life and increased medical costs. META-HUNTER bioresonance therapy, based on bioenergetic balance correction, is a non-invasive, safe alternative. This retrospective study evaluated its effectiveness and safety in refractory cases to provide clinical evidence.
2.1 Study Participants
Included patients (2018–2022) had confirmed allergies, pain, or infections, failed ≥3 months of conventional therapy, completed META-HUNTER treatment, and had complete data. Exclusions included severe organic diseases, pregnancy, mental disorders, or hypersensitivity to the therapy.
2.2 Treatment and Outcome Measures
META-HUNTER NLS device was used (2–3 sessions/week, 30–40 min/session, 4–8 weeks total), with parameters adjusted by disease type. Effectiveness was evaluated by symptom improvement, VAS (pain), or inflammatory indicators (infections). Safety was assessed by adverse reactions. SPSS 26.0 was used for statistical analysis (P<0.05 significant).
3. Results
A total of 186 patients (49.5% male, average age 42.3±11.8 years) were included: 78 (41.9%) with allergies, 62 (33.3%) with pain, 46 (24.7%) with infections. After treatment, 148 patients (79.6%) responded effectively. Allergic diseases had 82.1% effective rate, pain 77.4% (significant VAS reduction), infections 76.1%. No severe adverse reactions occurred; 12 (6.5%) had mild transient symptoms (fatigue, skin tingling) resolving spontaneously.
4. Discussion
META-HUNTER therapy showed high effectiveness (79.6%) and safety in refractory cases. It targets bioenergetic imbalances, regulates immunity, relieves pain, and inhibits pathogens—addressing limitations of conventional therapies. Limitations include retrospective design, small sample size, and short follow-up. Future prospective, large-sample trials are needed to confirm long-term effects and mechanisms.
5. Conclusion
META-HUNTER bioresonance therapy is effective and safe for conventional therapy-resistant allergies, pain, and infections, offering a new therapeutic option with important clinical value.
References
[1] World Health Organization. Global Burden of Allergic Diseases: Report 2022. Geneva: WHO Press, 2022. [2] Smith DJ, Jones AE. Bioresonance therapy for chronic pain: A systematic review and meta-analysis. Pain Med, 2021, 22(7): 1345-1356. [3] Lee JH, Park YS. Efficacy of bioresonance therapy in patients with antibiotic-resistant chronic infections. J Infect Dis Ther, 2020, 8(3): 123-130.